Does ALECTINIB Cause Non-small cell lung cancer? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Non-small cell lung cancer have been filed in association with ALECTINIB (ALECENSA). This represents 0.4% of all adverse event reports for ALECTINIB.
38
Reports of Non-small cell lung cancer with ALECTINIB
0.4%
of all ALECTINIB reports
14
Deaths
6
Hospitalizations
How Dangerous Is Non-small cell lung cancer From ALECTINIB?
Of the 38 reports, 14 (36.8%) resulted in death, 6 (15.8%) required hospitalization.
Is Non-small cell lung cancer Listed in the Official Label?
Yes, Non-small cell lung cancer is listed as a known adverse reaction in the official FDA drug label for ALECTINIB.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which ALECTINIB Alternatives Have Lower Non-small cell lung cancer Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE